Simulations Plus, Inc. showcased ADMET Predictor 14 with enhanced support for beyond Rule of 5 compounds, workflow improvements, and a preview of the new AI-enabled platform.
Public source
Publisher name
Public post
Drug discovery isn't standing still—and neither should your predictive modeling tools. Join Dr. Jeremy Jones and Dr. David Miller as they showcase the latest capabilitie…
Company
Simulations Plus, Inc.
Where are you in the drug development process? Save resources & get to market faster with our solutions!
- Industry
- Software Development
- Location
- Durham, US
- Company size
- 201–500 employees
About Simulations Plus, Inc.
Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide. For more information visit us at www.simulations-plus.com
See moreLatest activity
Latest activity from Simulations Plus, Inc.
8 signals
Presence & Recognition
Simulations Plus, Inc. experts Lynzie Worth and Jenna Rouse will be at DPHARM 2026
Presence & Recognition
Simulations Plus, Inc. hosted the workshop titled Biopharma AI Operating Platform and in silico Early-Stage ADME/PK/PD Modeling for Beginners: Introduction to Real-World Application Cases at the Korea Chapter of the Pharmaceutical & BioScience Society International (Korea-PBSS)
Research & Knowledge
Simulations Plus, Inc. published a blog post by Dr. Jeremy Jones discussing where mechanistic modeling and AI are intersecting in the discovery space.
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
BioSolveIT
BioSolveIT provides free access to SeeSAR and Chemical Space Docking (C-S-D) until November 15, 2026, as part of the company's 25th anniversary.
Products & Services
Aplos Analytics, Inc.
Aplos Analytics, Inc. released a new feature in Aplos NCA called Non-Linear Model Fitting, which allows users to fit 1-, 2-, and 3-compartment PK models for IV bolus and IV infusion data, as well as six models for extravascular administration with and without a lag time.
Products & Services
OpenADMET
OpenADMET launched Model Validation Central, a platform for re-running published molecular ML methods on the ExpansionRx and Biogen ADME datasets across 25 replicates.
Products & Services
Deep MedChem
Deep MedChem increased the API calls limits for all CHEESE cloud service tiers by 10x for September to allow evaluation with fewer constraints.
Products & Services
Schrödinger